First Solar Faces Class Action Lawsuit, Adding Legal Overhang to Policy and Execution Risks
Read source articleWhat happened
A class action lawsuit has been filed against First Solar for alleged misrepresentations between February 2025 and February 2026, adding a new legal overhang to an already policy-sensitive stock. The suit claims investors suffered losses during a period when the company's stock fell sharply after weak sales guidance in February 2026. Our analysis shows First Solar's current valuation at $257.7 already prices in sustained policy-driven economics, but now faces additional legal risk that could weigh on sentiment. The company's reported gross margins are heavily levered to Section 45X credits (Q1'26: $418M in credits), and this lawsuit does not change the fundamental dependence on policy durability and trade enforcement. However, it introduces another layer of uncertainty that may delay buying decisions and increase volatility in the near term.
Implication
The class action lawsuit adds litigation risk that could result in financial penalties or settlement costs, though it is unlikely to be a thesis breaker unless it materially impacts management focus or contract negotiations. Our WAIT rating already accounts for policy and execution risks, and this legal overhang reinforces the need for patience until key catalysts like Section 232 decision and U.S. booking ASPs materialize. The attractive entry of $230 provides a wider margin of safety if the stock dips further on lawsuit-related headline risk. Investors should monitor the lead plaintiff deadline of August 24, 2026, as sustained selling pressure could present a buying opportunity if fundamentals remain intact. Ultimately, the lawsuit does not change the fundamental value drivers but may prolong the re-assessment window and increase near-term volatility.
Thesis delta
The class action lawsuit increases the legal and headline risk for First Solar, modestly raising the probability of the bear case scenario (30% to 35%) and lowering conviction within the WAIT rating from 3.5 to 3.0. However, the core thesis - that the stock's value depends on policy-driven margins and trade enforcement outcomes - remains unchanged.
Confidence
Medium